Biodeal Pharmaceuticals Limited has appointed Visionary Leader Mr. Rishi Kapoor as its Chief Financial and Business Officer (CFBO), strengthening the company’s leadership team for its next phase of growth.

Rishi brings over 20 years of financial leadership experience across Pharma & Healthcare, EdTech, IT, and Retail, with senior roles at Girnar Group, Corbus LLC, Amrapali Group, Future Group, and Max Healthcare. He has extensive expertise in strategic finance, fundraising, investor relations, M&A, and IPO management, successfully driving high-value acquisitions, equity and debt raises, and transformative financial initiatives across geographies.

A Chartered Accountant, Master in Finance, and Lifetime Certified Independent Director, Rishi was recognized among India’s Top 10 Most Dynamic Revenue and Growth Leaders 2025 by TradeFlock, underscoring his excellence in driving business growth.

In his new role at Biodeal, Rishi will lead the company’s financial strategy, investor engagement, and automation of financial processes, while spearheading the company’s upcoming IPO journey, ensuring strong foundations for sustainable growth.